Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice

Journal of Clinical Investigation

Volumn 111, Issue 6, 2003, Pages 897-906

  Sukhova, Galina K ^a   Zhang, Yaou ^b   Pan, Jie Hong ^b   Wada, Youichiro ^c   Yamamoto, Takashi ^c   Naito, Makoto ^c   Kodama, Tatsuhiko ^c   Tsimikas, Sotirios ^d   Witztum, Joseph L ^d   Lu, Michael L ^a   Sakara, Yasuhiko ^a   Chin, Michael T ^a   Libby, Peter ^a   Shi, Guo Ping ^b,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; CD4 ANTIGEN; COLLAGEN; CYSTATIN C; CYSTEINE PROTEINASE; ELASTASE; GAMMA INTERFERON; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; CATHEPSIN; ELASTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROMATOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BASEMENT MEMBRANE; CELL MIGRATION; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME DEFICIENCY; GENE OVEREXPRESSION; INTIMA; KNOCKOUT MOUSE; LYSOSOME; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; T LYMPHOCYTE SUBPOPULATION; ANIMAL; ARTERIOSCLEROSIS; C57BL MOUSE; CELL MOTION; CHEMISTRY; CYTOLOGY; LEUKOCYTE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RABBIT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; CATHEPSINS; CELL MOVEMENT; COLLAGEN; ELASTIN; LEUKOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; RABBITS; RECEPTORS, LDL;

EID: 0037362831     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200314915     Document Type: Article

References (57)

1. Sukhova, G.K., Shi, G.P., Simon, D.I., Chapman, H.A., and Libby, P. 1998. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 102:576-583.
2. Shi, G.P., et al. 1999. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest. 104:1191-1197.
3. Libby, P. 2000. Changing concepts of atherogenesis. J. Intern. Med. 247:349-358.
4. Moons, L., et al. 1998. Reduced transplant arteriosclerosis in plasminogen-deficient mice. J. Clin. Invest. 102:1788-1797.
5. Carmeliet, P., Moons, L., Ploplis, V., Plow, E., and Collen, D. 1997. Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J. Clin. Invest. 99:200-208.
6. Carmeliet, P., et al. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17:439-444.
7. Galis, Z.S., Sukhova, G.K., Lark, M.W., and Libby, P. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493-2503.
8. Sukhova, G.K., et al. 1999. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 99:2503-2509.
9. Herman, M.P., et al. 2001. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J. Clin. Invest. 107:1117-1126.
10. Brown, D.L., Hibbs, M.S., Kearney, M., Loushin, C., and Isner, J.M. 1995. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation. 91:2125-2131.
11. Henney, A.M., et al. 1991. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. U. S.A. 88:8154-8158.
12. Halpert, I., et al. 1996. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad. Sci. U S. A. 93:9748-9753.
13. Jormsjo, S., et al. 2000. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ. Res. 86:998-1003.
14. Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., and Tschesche, H. 2000. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J. Biol. Chem. 275:33008-33013.
15. Allaire, E., Forough, R., Clowes, M., Starcher, B., and Clowes, A.W. 1998. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J. Clin. Invest. 102:1413-1420.
16. Rouis, M., et al. 1999. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation. 100:533-540.
17. Xin, X.Q., Gunesekera, B., and Mason, R.W. 1992. The specificity and elastinolytic activities of bovine cathepsins S and H. Arch. Biochem. Biophys. 299:334-339.
18. Shi, G.P., Munger, J.S., Meara, J.P., Rich, D.H., and Chapman, H.A. 1992. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267:7258-7262.
19. Maciewicz, R.A., and Etherington, D.J. 1998. A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. Biochem. J. 256:433-440.
20. Shi, G.P., et al. 1999. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity. 10:197-206.
21. Nakagawa, T.Y., et al. 1999. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity. 10:207-217.
22. Hansson, G.K. 2001. Regulation of immune mechanisms in atherosclerosis. Ann. N. Y. Acad. Sci. 947:157-165.
23. Robbie, L., and Libby, P. 2001. Inflammation and atherothrombosis. Ann. N. Y. Acad. Sci. 947:167-179.
24. Ishibashi, S., et al. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
25. Lichtman, A.H., et al. 1999. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler. Thromb. Vasc. Biol. 19:1938-1944.
26. Ray, J.L., Leach, R., Herbert,J.M., and Benson, M. 2001. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci. 23:185-188.
27. Mach, F., Schonbeck, U., Sukhova, G.K., Atkinson, E., and Libby, P. 1998. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature. 394:200-203.
28. Takaku, M., et al. 1999. An in vitro coculture model of transmigrant monocytes and foam cell formation. Arterioscler. Thromb. Vasc. Biol. 19:2330-2339.
29. Ausryn, J.M., and Gordon, S. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:805-815.
30. Honda, M., et al 1998. Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer's disease. Biochem. Biophys. Res. Commun. 245:734-740.
31. Ishibashi, S., Goldstein, J. L., Brown, M.S., Herz, J., and Burns, D.K. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93:1885-1893.
32. Davies, M.J., Richardson, P.D., Woolf, N., Katz, D.R., and Mann, J. 1993. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br. Heart J. 69:377-381.
33. -/- mice. Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol. 16:1013-1018.
34. Hansson, G.K., Libby, P., Schonbeck, U., and Yan, Z.Q. 2002. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91:281-291.
35. Huo, Y., et al. 2001. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J. Clin. Invest. 108:1307-1314. doi:10.1172/JCI200112877.
36. Libby, P., Sukhova, G., Lee, R.T., and Galis, Z.S. 1995. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J. Cardiovasc. Pharmacol. 25(Suppl. 2):S9-S12.
37. Farb, A., et al. 1996. Coronary plaque erosion without rupture in to a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 93:1354-1363.
38. Libby, P., Ganz, P., Schoen, F.J., and Lee, R.T. 2000. The vascular biology of the acute coronary syndromes. In Acute coronary syndromes. E.J. Topol, editor. Marcel Dekker Inc. New York, New York, USA. 33-57.
39. Maciewicz, R.A., and Etherington, D.J. 1988. A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. Biochem. J. 256:433-440.
40. Chapman, H.A., Riese, R.J., and Shi, G.-P. 1997. Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59:63-88.
41. Reddy, V.Y., Zhang, Q.Y., and Weiss, S.J. 1995. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. U. S. A. 92:3849-3853.
42. Punturieri, A., et al. 2000. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J. Exp. Med. 192:789-799.
43. De Meyer, G.R., and Bult, H. 1997. Mechanisms of neointima formation-lessons from experimental models. Vasc. Med. 2:179-189.
44. Li, D.Y., et al. 1998. Elastin is an essential determinant of arterial morphogenesis. Nature. 393:276-280.
45. Amento, E.P., Ehsani, N., Palmer, H., and Libby, P. 1991. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 11:1223-1230.
46. Murray, K., de Lera, J.M., Astudillo, A., and McNicol, A.M. 1997. Organisation of basement membrane components in the human adult and fetal pituitary gland and in pituitary adenomas. Virchows Arch. 431:329-335.
47. Randolph, G.J., Luther, T., Albrecht, S., Magdolen, V., and Muller, W.A. 1998. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood. 92:4167-4177.
48. Randolph, G.J., Sanchez-Schmitz, G., Liebman, R.M., and Schakel, K. 2002. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J. Exp. Med. 196:517-527.
49. Valente, A.J., Rozek, M.M., Sprague, E.A., and Schwartz, C.J. 1992. Mechanisms in intimal monocyte-macrophage recruitment. A special role for monocyte chemotactic protein-1. Circulation. 86(Suppl. 6):11120-11125.
50. Moulton, K.S. 2001. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep. 3:225-233.
51. Celletti, F.L., et al. 2001. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. 7:425-429.
52. Moulton, K.S., et al. 1999. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 99:1726-1732.
53. Libby, P., and Schonbeck, U. 2001. Drilling for oxygen: angiogenesis involves proteolysis of the extracellular matrix. Circ. Res. 89:195-197.
54. Bui, M.N., et al. 1996. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am. Heart J. 131:663-667.
55. Palinski, W., Tangirala, R.K., Miller, E., Young, S.G., and Witztum, J.L. 1995. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15:1569-1576.
56. Metian, A., Geng, Y.J., Sukhova, G.K., Libby, P., and Porcelli, S.A. 1999. CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. Am. J. Pathol. 155:775-786.
57. Riese, R.J., et al. 2001. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. Immunity. 15:909-519.